What Gives Moderna's Coronavirus Vaccine an Edge?
In this episode of MarketFoolery, Chris Hill chats with Motley Fool analyst Bill Barker about the latest headlines from Wall Street. They discuss what gives Moderna's (NASDAQ: MRNA) vaccine candidate an edge over Pfizer's (NYSE: PFE), and also talk about how the markets reacted to the news. They've got a couple of merger and acquisition deals in real estate to discuss, home improvement and banking developments to share, and much more.
To catch full episodes of all The Motley Fool's free podcasts, check out our podcast center. To get started investing, check out our quick-start guide to investing in stocks. A full transcript follows the video.
Source Fool.com
